Ischemic Heart
Disease
Coronary artery disease
• Risk factors for coronary artery disease
• Pathogenesis
• Clinical presentation
• Treatment overview
Risk factors for coronary
artery disease
Risk Factors for Coronary artery
disease
Non-modifiable
 Age
 Family history
 Sex
Modifiable
 Cigarette smoking
 Diabetes mellitus
 Hyperlipidemia
 Hypertension
Other less important risk factors
• Obesity
• Physical inactivity
• Stress ( type A personality)
• Postmenopausal estrogen deficiency
• Alcohol
Pathogenesis of coronary
artery disease
Atherosclerosis
The underlying pathogenesis of
coronary arterial disease is
atherosclerosis
Atherosclerosis
Atherosclerosis = “Hardening of the vessels”
Smoking
Blood
pressure
Cholesterol
Diabetes
mellitus
Other
factors
Atherosclerosis Thrombosis Heart attack
Brain attack
Other
vascular
Development of atherosclerosis
Atherosclerosis
• The key processes in atherosclerosis are
– intimal thickening
– lipid accumulation
• These processes will produced the atheromatous plaque
Atheromatous plaque
Atheroma in coronary artery
Atheromatous plaque/ Atheroma
Fatty streak
Atheroma
Response to Injury Hypothesis
• Atherosclerosis is a chronic inflammatory response of
the arterial wall initiated by some form of injury to the
endothelium
Smooth endothelium
Chronic repetitive injury
Smoking Hypertension Hyperlipidemia
Endothelial
injury
Response to injury
Pathogenesis of myocardial
ischemia
Coronary artery atherosclerosis
• Most of the patients with coronary artery disease has
coronary atherosclerosis which cause obstruction to
blood flow
Effect of atherosclerosis
• Most have one or more lesions causing at least 75%
reduction of the cross-sectional area of coronary arteries
• Coronary Artery Disease = insufficient flow of blood
through coronary arteries
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Asymptomatic
• The degree of obstruction sometimes do not correlate
with symptoms.
• Patient may be still asymptomatic despite high degree of
obstruction
• Patient may also loss the sensation of pain as a result of
neuropathy especially with diabetes mellitus
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Sudden death
• May be the first manifestation in 25% of patients
• 20% of patients with AMI will died before
reaching hospital
• Most of these death are caused by ventricular
fibrillation
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Angina Pectoris
• Imbalance of oxygen supply and demand
• Decreased blood flow to myocardium
• Results in chest pain
– Switch to anerobic metabolism
– Lactic acid build up
– Kinins, histamine, other substances released
– Nerve fibers are stimulated
Angina Pectoris
• paroxysmal and usually recurrent attacks of substernal
or precordial chest discomfort
• described as constricting, squeezing, choking, or
knifelike
Typical Angina
Typical Angina
Typical Angina
• Retrosternal chest pain
– Dull
– Pressing
• Aggravated by exertion
• Relieved by GTN or by rest
• Associated with nausea, vomiting and sweating
Canadian Cardiovascular Society (CCS)
ANGINA
Functional Class Symptoms
I Normal ordinary activity
Angina with strenuous exercise
II Slight limitation of ordinary activity
III Marked limitation of ordinary activity
IV Inability to perform any activity without
symptom. May be present at rest
Typical Angina
Types of angina
Angina
Stable angina
Prinzmetal variant
angina
Unstable angina
Stable angina
• Also called exertional angina
• The lumen of coronary artery is narrowed and hard; thus,
dilation in response to increased demand is impossible
Stable angina
• Initiated by known amount of activity
• Same activity tends to produce same symptoms
• Produced by
– physical activity
– emotional excitement
– cause of increased cardiac workload
• Relieved by rest, Nitrate
Printzmetal angina
• Also called variant angina, Prinzmetal’s variant angina
• An uncommon pattern of episodic angina that occurs at
rest
• Due to coronary artery spasm.
Printzmetal angina
• Occurs without a precipitating event, usually at the same
time of day
• Often awakens patient from sleep
• Unpredictable, occurs most often at rest
Coronary Angioplasty
Before After
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Acute coronary syndrome
Acute
Coronary
Syndrome
Unstable
angina
Non-ST
Elevation
Myocardial
Infarct
Acute
Myocardial
infarct
ATHEROMATOUS PLAQUE
PLAQUE RUPTURE
ATHEROMATOUS PLAQUE
PLAQUE RUPTURE
ATHEROMATOUS PLAQUE PLAQUE RUPTURE
PLAQUE RUPTURE
Clinical features of Acute Myocardial
Infarction
• Angina
– Prolonged
– Not relieved by usual dose of nitrates
• Sweating
• Nausea and vomiting
• Palpitation
• Dyspnea
• Sudden death
Acute coronary syndrome
• Angina occurs at rest or on minimum exertion
• Not relieved by usual doses of GTN
• The pain last longer (> 20 minutes)
• Increasing in duration/severity/frequency
Acute Coronary Syndrome
ECG changes of AMI
Anterior myocardial infarct
Inferior myocardial infarct
Cardiac enzymes
• Myoglobulin
• Troponin
• Creatinine kinase (MB)
• ALT
• Lactate dehydrogenase
Cardiac Enzymes in ACS
Cardiac Enzymes in ACS
Test Onset Peak Duration
Myoglobulin 1-4 hours 6-7 hours 24 hours
Troponin 3-12 hours 18-24 hours Up to 10 days
CK-MB 3-12 hours 18-24 hours 36-48 hours
LDH 6-12 hours 24-48 hours 6-8 days
Acute Coronary Syndrome
Non ST elevation MI
• Typical chest pain
• Raised cardiac enzymes
• NO ST elevation in ECG
– But may have other ECG changes
NSTEMI: ECG changes
Acute Coronary Syndrome
Unstable angina
• Chest pain
• NO cardiac enzyme changes
• NO ST elevation in ECG
Acute coronary syndrome
Acute
Coronary
Syndrome
Unstable
angina
Non-ST
Elevation
Myocardial
Infarct
Acute
Myocardial
infarct
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Heart failure
• In recurrent myocardium ischemia, the myocardium will
loss function
• This will progress to reduced left ventricular function and
cause heart failure
Signs and symptoms
• Orthopnea
• Reduced effort tolerance
• Paroxysmal nocturnal dyspnea
• Raised JVP
• Acute pulmonary edema
Orthopnea
• Unable to lie flat
• Sometimes need to sit up to sleep
• Severity judged by number of pillows
required to sleep on
Paroxysmal Nocturnal Dyspnea
• waking up in about 2-3 am
• breathlessness
Lying
Down
Acute pulmonary edema
ECHO: Poor LVEF
• Dilated LV
• Dilated LA
• Globally poor LV contraction
Treatment
End of Phase II 11.8.09
Lifestyle modifications
Smoking
Diabetes
Male
Hypertension
Obesity
Lack of exercise
Stress
Lifestyle modifications
Lifestyle modifications
Antiplatelet
• Aspirin
• ADP receptor antagonist
– Ticlopidine
– Clopidogrel
Antiplatelet
• Chronic angina
– Aspirin for life
– ADP receptor antagonist if aspirin intolerable
• Acute coronary syndrome
– Dual antiplatelet
Thrombolytic
• Lyse the clot that block the blood flow
• Examples
– Streptokinase
– rTPA
• Only in acute myocardial infarct
Anticoagulant - Heparin
• Heparin
• Low molecular weight heparin
• oligosaccharides (fondaparinux)
• Heparinoid
Anticoagulant - Heparin
• Used in acute coronary syndrome
• Currently favors oligosaccharides (fondaparinux)
– Less bleeding complications
– Single daily injection
– Halal
COX (cyclo-oxygenase)
ADP (adenosine diphosphate)
TXA2 (thromboxane A2)
Thienopyridines
ASA COX
ADP
ADP
C
GPllb/llla
(Fibrinogen receptor)
Collagen thrombin
TXA2
Activation
TXA2
ASA
Synergistic Mode of Action with
Clopidogrel and ASA1
1. Schafer AI. Am J Med 1996; 101: 199–209.
Glycoprotein IIb/IIIa inhibitors
• Examples
– Abciximab
– Tirofiban
– Eptifibatide
• Used mainly in
– Unstable angina
– NSTEMI
Primary PCI - 1
Aspirated clot
Primary PCI - 2
PCI of coronary artery
•The narrowing was
openned with a
angioplasty balloon
• A stent was inflated
after the balloon
angioplasty
Coronary bypass surgery
Coronary artery disease
• ACE inhibitor/Angiotensin receptor blocker
• Beta Blocker
• Calcium channel blocker if not tolerable to beta blocker
Treat the concomitant conditions
• Hypertension
• Diabetes Mellitus
• Hyperlipidemia
Summary
Smoking
Blood
pressure
Cholesterol
Diabetes
mellitus
Other
factors
Atherosclerosis Thrombosis Heart attack
Brain attack
Other
vascular
Development of atherosclerosis
Presentation of coronary heart
disease
Asymptomatic Chronic stable
angina
Acute coronary
syndrome (ACS) Death
(MI = Myocardial Infarction)
Unstable angina
Non ST elevation MI
ST elevation MI
Heart failure
Acute Coronary Syndrome
End of Phase II

Ischemic Heart Disease